- Home
- BMRN vs ALV Comparison
BMRN vs ALV Comparison
Compare BMRN & ALV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BMRN
- ALV
- Stock Information
- Founded
- BMRN 1996
- ALV 1953
- Country
- BMRN United States
- ALV Sweden
- Employees
- BMRN N/A
- ALV N/A
- Industry
- BMRN Biotechnology: Pharmaceutical Preparations
- ALV Auto Parts:O.E.M.
- Sector
- BMRN Health Care
- ALV Consumer Discretionary
- Exchange
- BMRN Nasdaq
- ALV Nasdaq
- Market Cap
- BMRN 10.0B
- ALV 9.7B
- IPO Year
- BMRN 1999
- ALV 1997
- Fundamental
- Price
- BMRN $52.08
- ALV $120.20
- Analyst Decision
- BMRN Buy
- ALV Buy
- Analyst Count
- BMRN 19
- ALV 9
- Target Price
- BMRN $90.89
- ALV $131.33
- AVG Volume (30 Days)
- BMRN 2.8M
- ALV 749.5K
- Earning Date
- BMRN 10-27-2025
- ALV 10-17-2025
- Dividend Yield
- BMRN N/A
- ALV 2.84%
- EPS Growth
- BMRN 59.53
- ALV 25.57
- EPS
- BMRN 2.68
- ALV 9.69
- Revenue
- BMRN $3,094,001,000.00
- ALV $10,614,000,000.00
- Revenue This Year
- BMRN $13.32
- ALV $4.45
- Revenue Next Year
- BMRN $7.51
- ALV $4.26
- P/E Ratio
- BMRN $19.59
- ALV $12.35
- Revenue Growth
- BMRN 12.39
- ALV 0.85
- 52 Week Low
- BMRN $51.00
- ALV $75.49
- 52 Week High
- BMRN $73.51
- ALV $129.54
- Technical
- Relative Strength Index (RSI)
- BMRN 42.64
- ALV 53.03
- Support Level
- BMRN $51.80
- ALV $114.50
- Resistance Level
- BMRN $54.25
- ALV $118.76
- Average True Range (ATR)
- BMRN 1.73
- ALV 2.38
- MACD
- BMRN -0.03
- ALV 0.50
- Stochastic Oscillator
- BMRN 18.34
- ALV 87.29
About BMRN BioMarin Pharmaceutical Inc.
BioMarin is a global biotechnology company focused on developing and commercializing therapies for rare genetic diseases. BioMarin specializes in enzyme replacement therapies, gene therapies, and other advanced treatments designed to address complex genetic disorders. The company has eight approved therapies for conditions including achondroplasia, phenylketonuria, hemophilia, and mucopolysaccharidosis. BioMarin has an expanding, yet relatively early-stage, pipeline of treatments in development across skeletal conditions and enzyme therapies.
About ALV Autoliv Inc.
Autoliv Inc is the world-wide leader in passive safety components and systems for the auto industry. Products include seat belts, frontal air bags, side-impact air bags, air bag inflators, and steering wheels. The Renault-Nissan-Mitsubishi alliance is the company's largest customer at 10% of 2023 revenue, with Stellantis accounting for 10% and Volkswagen 9%. At 34% of 2023 revenue, the Americas was Autoliv's largest geographic region, followed by Europe at 27%, China at 20%, and rest of world at 19%.